Enzymatic conversion and hybrid capture target enrichment combine to optimize methylation sequencing.

Making filtration devices easier to clean reduces fatigue and injury risk while improving reproducibility.

New cytokine analysis technology advances cancer therapeutics and vaccine development.

Special steps are needed to optimize qPCR results for wastewater analysis and surveillance.

An integrated system rapidly measures DNA and RNA without sample loss.

From identifying targets to testing lead candidates, developing antibodies into clinical therapies is a process full of twists and turns.

Functional profiling of immune cells uncovers targetable mechanisms underlying lung inflammation in severe COVID disease.

Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.

Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.

Skin symptoms are often the first, or only, symptom of COVID-19.

Automated powder dispensing and dosing improve accuracy and reliability.

Keep 3D printer workflows for tissue and cell culture contaminant free.

An automated cell counter accurately analyzes nuclei isolated from tissue samples.

Gene synthesis and protein services bypass time-consuming steps and produce optimized results.

Early detection with microfluidic modulation spectroscopy (MMS) addresses protein instability and loss of function.

Syrris has joined the photochemistry movement with its new Asia Photochemistry Reactor. The latest addition to the company’s award-winning Asia Flow Chemistry range, the Asia Photochemistry Reactor enables a host of novel photochemistry applications in flow across a variety of sectors – including pharmaceuticals, petrochemicals, agrochemicals and fine chemicals, as well as in academic institutions.

Using High-Plex Spatial Proteomics to Examine Immune Response

Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.

Researchers developed a new CAR T-cell therapy that targets specific growth factor receptors in glioblastoma to eliminate brain tumors.